QuantalX Neuroscience Announces CE MDR Approval, Making Brain Health Assessment Available in the EU

The company announces CE MDR approval for its novel Delphi-MD neurodiagnosis medical device in preparation for EU commercialization, improving patients' clinical outcomes and well being while reducing healthcare systems and payors' financial burden.

NEW YORK, Feb. 12, 2025 /PRNewswire/ --QuantalX Neuroscience Ltd. is proud to announce that its groundbreaking brain health assessment device, the Delphi-MD, has received CE MDR approval, the European Union's certification under the new Medical Device Regulation (MDR). The CE MDR certification process sets a new benchmark for safety, efficacy, and quality in medical devices. This achievement underscores QuantalX's commitment to innovation and excellence in neurological care.